• AZD3463: Rethinking ALK-Driven Resistance

  2026-09-07

  A translational framework for using AZD3463 as an ALK/IGF1R inhibitor to connect genotype, PI3K/AKT/mTOR signaling, apoptosis, autophagy, and chemotherapy response in neuroblastoma research.

• HyperPFU™ high-fidelity DNA polymerase

  2026-09-05

  HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, and otherwise difficult DNA templates where processivity and proofreading are important. It produces blunt-ended PCR products, so it should not be selected for workflows that require 3′-A overhangs or preformed sticky ends.

• Navitoclax Enhances mTOR Inhibition in PIK3CA CRC

  2026-09-05

  DeStefanis and colleagues identified navitoclax as a combination partner that enhances PI3K/mTOR pathway inhibition in PIK3CA-mutant colorectal cancer models. Their organoid-to-animal study links the response primarily to BCL-xL dependence and suggests that KRAS mutation may limit activity, providing a biomarker-informed framework for apoptosis-focused combination research.

• Salvianolic acid B for Reliable Cell Assays

  2026-09-04

  Learn how Salvianolic acid B (SKU N1806) can improve experimental control in viability, proliferation, and pulmonary fibrosis assays. This scenario-based guide covers assay interference, solvent compatibility, dose optimization, mechanistic interpretation, and product reliability using documented quality and handling data.

• 0.4% Trypan Blue Solution: Practical Guide

  2026-09-04

  0.4% Trypan Blue Solution provides a direct membrane-integrity readout for cell viability measurement, cell counting, and research cytotoxicity workflows. It is intended for scientific research only and should not be used for diagnostic, medical, or clinical applications.

• Propidium iodide Workflows for Immune Cell Analysis

  2026-09-03

  Build sharper viability, apoptosis, and DNA-content assays with Propidium iodide, from routine flow cytometry to placenta–immune cell models. The workflow below separates membrane integrity from proliferation and T-cell phenotype, helping researchers interpret complex exosome experiments with greater confidence.

• Hoechst 33342 Workflows for GERD Cell Assays

  2026-09-03

  Use Hoechst 33342 to convert nuclear morphology into a practical readout for bile acid-stressed epithelial cells, cell-cycle profiling, and apoptosis-oriented imaging. This workflow complements the TAS2R38/TRPV1 GERD model while clearly separating validated findings from assay-level recommendations.

• CAPE Workflows for NF-κB Neuroinflammation Research

  2026-09-02

  Caffeic Acid Phenethyl Ester (CAPE) provides a selective way to interrogate NF-κB-dependent inflammation in cell and zebrafish models. This workflow connects Fyn–Stat3 neurodegeneration biology with practical assay design, while also supporting carefully separated tumor invasion and angiogenesis studies.

• Sulfisomidine (Sulfamethin) Research Workflows

  2026-09-02

  Sulfisomidine connects sulfonamide antibacterial research with hPON1 inhibition, making it useful for enzyme kinetics, microbial metabolism, and environmental transformation studies. This practical guide covers preparation, assay design, matrix controls, troubleshooting, and how to interpret historical pertussis data without confusing clinical evidence with modern laboratory recommendations.

• Phytol Mechanisms: RXR, GABA_A, and Assay Design

  2026-09-01

  Phytol is a multifunctional diterpene whose RXR, GABAergic, and metabolic effects require carefully separated assays. This article applies a phase-and-kinetics insight from modern bottlebrush polymer research to improve phytol mechanism attribution without conflating unrelated biological and materials systems.

• Trichostatin A (TSA): Applied Research Workflow

  2026-09-01

  Trichostatin A (TSA) gives researchers a reversible way to connect HDAC inhibition with histone acetylation, cell-cycle control, differentiation, and cancer phenotypes. This workflow also shows how TSA perturbation can be paired cautiously with real-time HO-1 activity imaging to separate epigenetic effects from downstream macrophage biology.

• MK 0893: Practical Glucagon Receptor Antagonism

  2026-08-31

  MK 0893 is a competitive, reversible glucagon receptor antagonist for connecting GCGR binding, cAMP signaling, and glucose regulation in one experimental workflow. Its extra-helical allosteric mechanism supports receptor mutagenesis, cell-based pharmacology, and translational diabetes studies while requiring careful attention to solubility, assay timing, and off-target controls.

• Cyclosporin A: Practical Protocol and QC Guide

  2026-08-30

  Cyclosporin A, also called cyclosporine, provides a controlled research tool for perturbing cyclophilin-linked immunosuppression, calcineurin-NFAT signaling, mitochondrial injury, and apoptosis-related readouts. Use the dossier conditions as starting points for model development, not as universal doses, and do not infer animal dosing, clinical efficacy, or broad antiviral activity without model-specific validation.

• Alfuzosin HCl: Assay Workflows for BPH Research

  2026-08-29

  Build sensitive Alfuzosin HCl assays for formulation screening, biological-fluid analysis, and mechanistic benign prostatic hyperplasia research. A micellar spectrofluorimetric workflow extends direct detection into the low-ng/mL range while providing practical controls for matrix effects, solution stability, and release testing.

• PEP Restricts cGAS Inflammation in Aging

  2026-08-29

  A 2026 Nature Aging study identifies phosphoenolpyruvate (PEP) as an endogenous metabolic brake on cGAS–STING-driven inflammation. Its combination of longitudinal profiling, mouse perturbation experiments, human association data, and mechanistic binding analyses links glycolytic state to inflammaging and neuroinflammation.

459 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page